Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Hemorrhage | 7 | 2015 | 185 | 2.000 |
Why?
|
| Equipment Contamination | 4 | 2020 | 38 | 1.860 |
Why?
|
| Capsule Endoscopy | 5 | 2022 | 10 | 1.400 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2018 | 171 | 1.060 |
Why?
|
| Endoscopes | 2 | 2015 | 36 | 1.010 |
Why?
|
| Colony Count, Microbial | 2 | 2015 | 77 | 0.990 |
Why?
|
| Endoscopy, Digestive System | 5 | 2018 | 78 | 0.870 |
Why?
|
| Duodenoscopes | 1 | 2020 | 7 | 0.750 |
Why?
|
| Gastric Bypass | 2 | 2017 | 83 | 0.680 |
Why?
|
| Gastrostomy | 2 | 2017 | 110 | 0.660 |
Why?
|
| Esophagitis | 2 | 2015 | 45 | 0.640 |
Why?
|
| Vascular Fistula | 1 | 2018 | 5 | 0.640 |
Why?
|
| Angiodysplasia | 2 | 2015 | 4 | 0.630 |
Why?
|
| Intestinal Fistula | 1 | 2018 | 26 | 0.630 |
Why?
|
| Abdominal Pain | 2 | 2016 | 97 | 0.620 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 3 | 2020 | 348 | 0.610 |
Why?
|
| Single-Balloon Enteroscopy | 1 | 2017 | 1 | 0.600 |
Why?
|
| Aortic Diseases | 1 | 2018 | 113 | 0.590 |
Why?
|
| Malnutrition | 1 | 2017 | 28 | 0.580 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 107 | 0.560 |
Why?
|
| Gastric Fistula | 1 | 2016 | 6 | 0.550 |
Why?
|
| Gastroscopy | 1 | 2016 | 45 | 0.540 |
Why?
|
| Histoplasmosis | 1 | 2015 | 5 | 0.530 |
Why?
|
| Immunocompetence | 1 | 2015 | 19 | 0.530 |
Why?
|
| Ulcer | 1 | 2015 | 27 | 0.530 |
Why?
|
| Tertiary Care Centers | 1 | 2015 | 67 | 0.520 |
Why?
|
| Electrocoagulation | 1 | 2015 | 35 | 0.510 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2015 | 17 | 0.510 |
Why?
|
| Digestive System Diseases | 1 | 2015 | 16 | 0.500 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 172 | 0.500 |
Why?
|
| Cecal Diseases | 1 | 2015 | 6 | 0.500 |
Why?
|
| Colitis | 1 | 2015 | 156 | 0.470 |
Why?
|
| Tuberculosis, Gastrointestinal | 1 | 2013 | 1 | 0.440 |
Why?
|
| Esophageal Perforation | 1 | 2013 | 13 | 0.440 |
Why?
|
| Referral and Consultation | 1 | 2015 | 383 | 0.440 |
Why?
|
| Mental Recall | 1 | 2013 | 72 | 0.420 |
Why?
|
| Colonic Polyps | 1 | 2013 | 63 | 0.420 |
Why?
|
| Gastroenterologists | 2 | 2022 | 11 | 0.420 |
Why?
|
| Inservice Training | 1 | 2012 | 68 | 0.410 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2013 | 103 | 0.400 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 221 | 0.400 |
Why?
|
| Colonoscopy | 1 | 2013 | 156 | 0.400 |
Why?
|
| Education, Nursing | 1 | 2012 | 55 | 0.390 |
Why?
|
| Humans | 28 | 2022 | 68618 | 0.360 |
Why?
|
| Infection Control | 2 | 2020 | 101 | 0.320 |
Why?
|
| Aged | 13 | 2018 | 14862 | 0.310 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 1140 | 0.270 |
Why?
|
| Middle Aged | 15 | 2017 | 21147 | 0.250 |
Why?
|
| Retrospective Studies | 6 | 2017 | 7277 | 0.250 |
Why?
|
| Intestine, Small | 2 | 2015 | 89 | 0.250 |
Why?
|
| Female | 15 | 2018 | 38074 | 0.240 |
Why?
|
| Aged, 80 and over | 8 | 2015 | 4848 | 0.240 |
Why?
|
| Male | 16 | 2017 | 37321 | 0.230 |
Why?
|
| Stents | 4 | 2009 | 657 | 0.220 |
Why?
|
| Cholestasis | 3 | 2009 | 90 | 0.210 |
Why?
|
| Disinfection | 2 | 2020 | 112 | 0.210 |
Why?
|
| Adult | 11 | 2015 | 21403 | 0.200 |
Why?
|
| Cholecystitis | 2 | 2009 | 12 | 0.170 |
Why?
|
| Prospective Studies | 4 | 2014 | 3705 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2016 | 7029 | 0.150 |
Why?
|
| Polyps | 1 | 2017 | 12 | 0.150 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2018 | 139 | 0.140 |
Why?
|
| Gastric Acid | 1 | 2017 | 71 | 0.140 |
Why?
|
| Stomach Neoplasms | 1 | 2017 | 64 | 0.140 |
Why?
|
| Reoperation | 2 | 2016 | 467 | 0.140 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2016 | 4 | 0.140 |
Why?
|
| Surgical Instruments | 1 | 2016 | 44 | 0.130 |
Why?
|
| Histoplasma | 1 | 2015 | 4 | 0.130 |
Why?
|
| Double-Balloon Enteroscopy | 1 | 2015 | 4 | 0.130 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2015 | 15 | 0.130 |
Why?
|
| Gastroenterostomy | 1 | 2015 | 8 | 0.130 |
Why?
|
| Common Bile Duct Neoplasms | 2 | 2005 | 12 | 0.130 |
Why?
|
| Choledochostomy | 1 | 2015 | 10 | 0.130 |
Why?
|
| Postoperative Hemorrhage | 1 | 2015 | 69 | 0.130 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2015 | 34 | 0.130 |
Why?
|
| Cecum | 1 | 2015 | 39 | 0.120 |
Why?
|
| Blood Urea Nitrogen | 1 | 2015 | 65 | 0.120 |
Why?
|
| Streptococcus | 1 | 2014 | 15 | 0.120 |
Why?
|
| Candida | 1 | 2014 | 15 | 0.120 |
Why?
|
| Enterococcus | 1 | 2014 | 29 | 0.120 |
Why?
|
| Dizziness | 1 | 2015 | 27 | 0.120 |
Why?
|
| Dilatation | 1 | 2015 | 58 | 0.120 |
Why?
|
| Renal Dialysis | 1 | 2015 | 174 | 0.120 |
Why?
|
| Colectomy | 1 | 2015 | 64 | 0.120 |
Why?
|
| Warfarin | 1 | 2015 | 93 | 0.120 |
Why?
|
| Patient Safety | 1 | 2016 | 202 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2016 | 652 | 0.120 |
Why?
|
| Pain, Postoperative | 1 | 2016 | 214 | 0.120 |
Why?
|
| Cost Savings | 1 | 2014 | 110 | 0.120 |
Why?
|
| Myocardial Ischemia | 1 | 2015 | 172 | 0.110 |
Why?
|
| Gastric Mucosa | 1 | 2013 | 77 | 0.110 |
Why?
|
| Poisson Distribution | 1 | 2013 | 85 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 365 | 0.100 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 219 | 0.100 |
Why?
|
| Telephone | 1 | 2013 | 160 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2015 | 356 | 0.100 |
Why?
|
| Endosonography | 2 | 2011 | 177 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2018 | 1615 | 0.100 |
Why?
|
| Calcinosis | 1 | 2013 | 241 | 0.100 |
Why?
|
| Observer Variation | 1 | 2012 | 330 | 0.100 |
Why?
|
| Consensus | 2 | 2022 | 211 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 2 | 2022 | 136 | 0.100 |
Why?
|
| Linear Models | 1 | 2013 | 521 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2013 | 1342 | 0.100 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2009 | 54 | 0.090 |
Why?
|
| Jaundice, Obstructive | 1 | 2009 | 8 | 0.090 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 756 | 0.080 |
Why?
|
| Foreign-Body Migration | 1 | 2009 | 38 | 0.080 |
Why?
|
| Cholecystectomy | 1 | 2009 | 79 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 800 | 0.080 |
Why?
|
| Time Factors | 2 | 2014 | 4655 | 0.080 |
Why?
|
| Drainage | 1 | 2009 | 133 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 332 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2012 | 657 | 0.070 |
Why?
|
| Metals | 1 | 2008 | 100 | 0.070 |
Why?
|
| Prosthesis Implantation | 1 | 2008 | 83 | 0.070 |
Why?
|
| Young Adult | 2 | 2015 | 5717 | 0.070 |
Why?
|
| South Carolina | 1 | 2013 | 2752 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 334 | 0.060 |
Why?
|
| Paraganglioma | 1 | 2005 | 8 | 0.060 |
Why?
|
| Ampulla of Vater | 1 | 2004 | 34 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 2800 | 0.060 |
Why?
|
| Catheterization | 1 | 2005 | 209 | 0.060 |
Why?
|
| Adolescent | 1 | 2015 | 8912 | 0.050 |
Why?
|
| Advisory Committees | 1 | 2022 | 73 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 2223 | 0.050 |
Why?
|
| Endoscopy | 1 | 2004 | 464 | 0.050 |
Why?
|
| United States | 1 | 2012 | 7367 | 0.040 |
Why?
|
| Detergents | 1 | 2018 | 34 | 0.040 |
Why?
|
| Sterilization | 1 | 2018 | 29 | 0.040 |
Why?
|
| Hepatitis B | 1 | 2018 | 42 | 0.040 |
Why?
|
| Gastric Acidity Determination | 1 | 2017 | 62 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2018 | 114 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2018 | 163 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2017 | 618 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2013 | 149 | 0.030 |
Why?
|
| Recurrence | 1 | 2015 | 948 | 0.030 |
Why?
|
| Biopsy | 1 | 2013 | 540 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2011 | 191 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2009 | 3259 | 0.020 |
Why?
|
| HIV Infections | 1 | 2018 | 791 | 0.020 |
Why?
|
| Pancreas | 1 | 2011 | 225 | 0.020 |
Why?
|
| Gallbladder | 1 | 2009 | 15 | 0.020 |
Why?
|
| Radiography | 1 | 2011 | 572 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2009 | 130 | 0.020 |
Why?
|
| Device Removal | 1 | 2008 | 100 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 1753 | 0.020 |
Why?
|
| Equipment Design | 1 | 2008 | 500 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2077 | 0.020 |
Why?
|
| Digestive System Neoplasms | 1 | 2005 | 13 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2005 | 267 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 2358 | 0.010 |
Why?
|
| Logistic Models | 1 | 2004 | 1420 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2005 | 778 | 0.010 |
Why?
|